Bisacodyl

Generic Name
Bisacodyl
Brand Names
Alophen Reformulated Jan 2008, Bi-peglyte, Bisac-evac, Carters Little Pills, Dulcolax, Fleet Mineral Oil, Gavilyte-H and Bisacodyl
Drug Type
Small Molecule
Chemical Formula
C22H19NO4
CAS Number
603-50-9
Unique Ingredient Identifier
10X0709Y6I
Background

Bisacodyl, a diphenylmethane derivative, is a commonly used over the counter stimulant laxative for occasional constipation. Both bisacodyl and picosulfate are metabolized to the same active metabolite bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM).

Bisacodyl was patented on 25 September 1956 but has been used as a laxative since 1952.

Indication

Bisacodyl is indicated to relieve occasional constipation and irregularity.

Associated Conditions
Bowel movement irregularity, Constipation, Occasional Constipation
Associated Therapies
Bowel preparation therapy

A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants

Phase 1
Completed
Conditions
Interventions
First Posted Date
2022-06-08
Last Posted Date
2023-03-22
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
7
Registration Number
NCT05409157
Locations
🇺🇸

Local Institution - 0001, Madison, Wisconsin, United States

RELISTOR's Effects on Opioid-Induced Constipation

First Posted Date
2021-06-18
Last Posted Date
2022-05-03
Lead Sponsor
Methodist Health System
Registration Number
NCT04930237
Locations
🇺🇸

Methodist Moody Brain and Spine Institute, Methodist Dallas Medical Center, Dallas, Texas, United States

Defecation Patterns in Constipated Patients

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2021-05-26
Last Posted Date
2024-01-10
Lead Sponsor
University of California, San Diego
Target Recruit Count
130
Registration Number
NCT04903470
Locations
🇺🇸

University of California San Diego, La Jolla, California, United States

Effect of PEG, Bisacodyl and Prucalopride on Colonic Motility in Healthy Subjects

First Posted Date
2017-09-12
Last Posted Date
2017-09-12
Lead Sponsor
University Hospital, Gasthuisberg
Target Recruit Count
10
Registration Number
NCT03279341
Locations
🇧🇪

TARGID, Leuven, Belgium

Reclassifying Constipation Using Imaging and Manometry

First Posted Date
2017-07-21
Last Posted Date
2020-07-07
Lead Sponsor
University of Nottingham
Target Recruit Count
120
Registration Number
NCT03226145
Locations
🇬🇧

Queen Mary University of London, London, United Kingdom

🇬🇧

University College London, London, United Kingdom

🇬🇧

University of Nottingham, Nottingham, Notts, United Kingdom

Comparison of Low Volume PEG-Asc and Lower Volume PEG-Asc With Bisacodyl

First Posted Date
2016-12-02
Last Posted Date
2016-12-02
Lead Sponsor
Korea University Anam Hospital
Target Recruit Count
200
Registration Number
NCT02980562

Treating Anorectal Dysfunction in MS

First Posted Date
2015-11-20
Last Posted Date
2020-01-22
Lead Sponsor
David Levinthal
Target Recruit Count
11
Registration Number
NCT02609607
Locations
🇺🇸

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure

First Posted Date
2015-06-25
Last Posted Date
2017-03-07
Lead Sponsor
Medtronic - MITG
Target Recruit Count
122
Registration Number
NCT02481219
Locations
🇺🇸

Franklin Gastroenterology, PLLC, Franklin, Tennessee, United States

🇺🇸

Indiana University Hospital, Indianapolis, Indiana, United States

🇺🇸

Pinnacle Research Group, LLC, Anniston, Alabama, United States

and more 3 locations

A Study Comparing Picoprep With Mannitol and Bisacodyl for Colon Cleansing in Preparation for Colonoscopy

First Posted Date
2015-03-12
Last Posted Date
2016-01-12
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
184
Registration Number
NCT02386449
Locations
🇧🇷

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (there may be other sites in this country), Sao Paulo, Brazil

Efficacy and Tolerability of Bisacodyl Sugar Coated Tablets, Simeticone Chewing Tablets and Their Combination in Constipation and Bloatedness

Phase 3
Completed
Conditions
Interventions
First Posted Date
2014-08-08
Last Posted Date
2014-08-08
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
30
Registration Number
NCT02211976
© Copyright 2024. All Rights Reserved by MedPath